Beauty Farm Medical & Health Industry (FRA:XC5) EBIT: €58.4 Mil (TTM As of Dec. 2025)


FRA:XC5 Beauty Farm Medical & Health Industry Inc FRA:XC5
85 GF Score
Price €1.67
GF Value €2.86
! 2 Warning Signs
View Full Analysis

What is Beauty Farm Medical & Health Industry EBIT?

Beauty Farm Medical & Health Industry FRA:XC5 -3.47% 85 EBIT is €58.4 Mil as of Dec. 2025. GuruFocus rates FRA:XC5 with a GF Score™ of 85/100 and a GF Value™ of €2.86. The stock has 2 warning signs investors should review.

Beauty Farm Medical & Health Industry's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was €29.8 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was €58.4 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Beauty Farm Medical & Health Industry's annualized ROC % for the quarter that ended in Dec. 2025 was 7.98%. Beauty Farm Medical & Health Industry's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 60.09%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Beauty Farm Medical & Health Industry's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 20.11%.


Beauty Farm Medical & Health Industry  (FRA:XC5) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Beauty Farm Medical & Health Industry's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=57.99 * ( 1 - 26.09% )/( (514.14 + 559.83)/ 2 )
=42.860409/536.985
=7.98 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=520.609 - 59.247 - ( 241.183 - max(0, 333.796 - 281.018+241.183))
=514.14

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=611.861 - 58.29 - ( 308.208 - max(0, 352.786 - 346.527+308.208))
=559.83

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Beauty Farm Medical & Health Industry's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=59.576/( ( (99.921 + max(-269.161, 0)) + (98.37 + max(-282.372, 0)) )/ 2 )
=59.576/( ( 99.921 + 98.37 )/ 2 )
=59.576/99.1455
=60.09 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3.993 + 18.11 + 13.686) - (59.247 + 0 + 245.703)
=-269.161

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(6.159 + 13.054 + 14.934) - (58.29 + 0 + 258.229)
=-282.372

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Beauty Farm Medical & Health Industry's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=58.351/290.169
=20.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beauty Farm Medical & Health Industry EBIT Related Terms


Beauty Farm Medical & Health Industry EBIT Historical Data

* Premium members only.

The historical data trend for Beauty Farm Medical & Health Industry's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beauty Farm Medical & Health Industry EBIT Chart

Beauty Farm Medical & Health Industry Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial 38.81 21.01 40.21 45.31 58.47

Beauty Farm Medical & Health Industry Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.92 22.39 22.38 28.56 29.79

FRA:XC5 vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Beauty Farm Medical & Health Industry's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beauty Farm Medical & Health Industry EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Beauty Farm Medical & Health Industry's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Beauty Farm Medical & Health Industry's EV-to-EBIT falls into.


FRA:XC5
85GF Score
Beauty Farm Medical & Health Industry Inc FRA:XC5
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beauty Farm Medical & Health Industry EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €58.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €58.4 Mil mean?
Beauty Farm Medical & Health Industry (FRA:XC5) has a EBIT of €58.4 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Beauty Farm Medical & Health Industry.
Is Beauty Farm Medical & Health Industry's EBIT too high?
Beauty Farm Medical & Health Industry's current EBIT is €58.4 Mil. Overall, Beauty Farm Medical & Health Industry has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Beauty Farm Medical & Health Industry's EBIT compare to HCA and THC?
Beauty Farm Medical & Health Industry's EBIT of €58.4 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Beauty Farm Medical & Health Industry. Beauty Farm Medical & Health Industry's current EBIT is €58.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beauty Farm Medical & Health Industry stock overvalued right now?
Beauty Farm Medical & Health Industry (FRA:XC5) has a current EBIT of €58.4 Mil. The stock's GF Value™ is €2.86, compared to a current price of €1.67 — trading 41.6% below its estimated fair value. The current EBIT is €58.4 Mil. Beauty Farm Medical & Health Industry's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Beauty Farm Medical & Health Industry (FRA:XC5), the current EBIT is €58.4 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beauty Farm Medical & Health Industry (FRA:XC5) Overvalued in 2026?

Based on GuruFocus' analysis, Beauty Farm Medical & Health Industry stock appears to be undervalued. The current stock price of €1.67 is trading 41.6% below its estimated GF Value™ of €2.86.

Key valuation signals for FRA:XC5:

  • EBIT: €58.4 Mil
  • GF Value™: €2.86 vs. price of €1.67 (41.6% below fair value)
  • GF Score™: 85/100 with 2 warning signs

No single metric tells the full story. See the FRA:XC5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Beauty Farm Medical & Health Industry Business Description

Other Exchanges 02373:Hong Kong
Address No. 1089 Dongdaming Road, Unit 1206, 12th Floor, Hongkou District, Shanghai, CHN
Beauty Farm Medical & Health Industry Inc. provides beauty and wellness services in the People's Republic of China. It offers high-quality beauty and wellness services, aesthetic medical services, and subhealth medical services according to customers' individual needs. The company offers its products and services through brands such as Beauty Farm, Palaispa, Naturade, Cellcare, and Neology.
85GF Score

Get the complete analysis for FRA:XC5

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.67
Price
€2.86
GF Value